Sculptor Capital LP Acquires 11,739,328 Shares of Kenvue Inc. $KVUE

Sculptor Capital LP raised its holdings in Kenvue Inc. (NYSE:KVUE) by 1,023.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 12,886,328 shares of the company’s stock after buying an additional 11,739,328 shares during the period. Kenvue accounts for about 2.3% of Sculptor Capital LP’s portfolio, making the stock its 6th largest holding. Sculptor Capital LP’s holdings in Kenvue were worth $222,289,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Slotnik Capital LLC acquired a new stake in Kenvue in the 4th quarter valued at $2,588,000. USS Investment Management Ltd increased its stake in Kenvue by 11.4% in the 4th quarter. USS Investment Management Ltd now owns 395,958 shares of the company’s stock valued at $6,840,000 after buying an additional 40,372 shares during the last quarter. Whetstone Capital Advisors LLC increased its stake in Kenvue by 7.3% in the 4th quarter. Whetstone Capital Advisors LLC now owns 13,463 shares of the company’s stock valued at $232,000 after buying an additional 919 shares during the last quarter. Yakira Capital Management Inc. acquired a new stake in Kenvue in the 4th quarter valued at $826,000. Finally, Vanguard Personalized Indexing Management LLC increased its stake in Kenvue by 11.9% in the 4th quarter. Vanguard Personalized Indexing Management LLC now owns 212,574 shares of the company’s stock valued at $3,667,000 after buying an additional 22,614 shares during the last quarter. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on KVUE. Zacks Research upgraded shares of Kenvue from a “hold” rating to a “strong-buy” rating in a research note on Friday, May 8th. Citigroup lowered their price target on shares of Kenvue from $20.00 to $19.00 and set a “neutral” rating on the stock in a research note on Wednesday, April 15th. UBS Group lowered their price target on shares of Kenvue from $19.00 to $18.00 and set a “neutral” rating on the stock in a research note on Tuesday, April 7th. Barclays lowered their price target on shares of Kenvue from $19.00 to $18.00 and set an “equal weight” rating on the stock in a research note on Tuesday, April 14th. Finally, Weiss Ratings downgraded shares of Kenvue from a “hold (c)” rating to a “hold (c-)” rating in a research report on Friday, May 29th. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and twelve have given a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $19.33.

Kenvue Stock Performance

Shares of KVUE opened at $18.25 on Tuesday. The firm has a 50-day moving average of $17.45 and a 200-day moving average of $17.55. Kenvue Inc. has a one year low of $14.02 and a one year high of $22.87. The company has a market cap of $35.03 billion, a PE ratio of 21.47, a price-to-earnings-growth ratio of 1.38 and a beta of 0.54. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.98 and a quick ratio of 0.70.

Kenvue (NYSE:KVUE) last announced its quarterly earnings data on Thursday, May 7th. The company reported $0.32 EPS for the quarter, beating analysts’ consensus estimates of $0.27 by $0.05. Kenvue had a net margin of 10.61% and a return on equity of 20.81%. The company had revenue of $3.91 billion during the quarter, compared to the consensus estimate of $3.84 billion. During the same quarter last year, the firm posted $0.24 EPS. The company’s quarterly revenue was up 4.5% on a year-over-year basis. As a group, equities analysts forecast that Kenvue Inc. will post 1.16 earnings per share for the current year.

Kenvue Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, May 27th. Stockholders of record on Wednesday, May 13th were given a $0.2075 dividend. This represents a $0.83 dividend on an annualized basis and a dividend yield of 4.5%. The ex-dividend date of this dividend was Wednesday, May 13th. Kenvue’s dividend payout ratio (DPR) is 97.65%.

Insider Activity at Kenvue

In related news, General Counsel Matthew Orlando sold 38,491 shares of Kenvue stock in a transaction dated Friday, May 8th. The shares were sold at an average price of $17.66, for a total transaction of $679,751.06. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 1.59% of the company’s stock.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.